Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Molina Healthcare To Sell MMS Unit For Business Streamlining

Published 06/27/2018, 11:24 PM
Updated 07/09/2023, 06:31 AM

Molina Healthcare, Inc. (NYSE:MOH) will be selling its wholly owned subsidiary Molina Medicaid Solutions (“MMS”), a Medicaid management information systems business, to DXC Technology Company (NYSE:DXC) .

MMS provides services to state agencies in the administration of Medicaid programs including business processing, information technology development and administrative services.
The unit was acquired by Molina Healthcare in 2010 from Unisys Corporation. It represented 1% of company revenues in 2017 and also carried a service margin ratio of 8%.

The sale expected to close during the third quarter of 2018, will fetch the company approximately $220 million. Funds from this deal will be invested in growing the company’s core business — Medicaid and Medicare. The company might also use part of the funds to pay debt, which will delever its balance sheet and strengthen its capital position.

Though the sale might dilute the company’s 2018 earnings, its effect will be nullified from the increased buyback the company would make from the released funds from the sale.

The sale came as no surprise and is one of the numerous efforts that management is making to build up the company’s profitability that should help it in the long term.

Another positive news for the stock is the receipt of Medicaid contract for two regions in Florida following the protest against initial awards. Molina Healthcare currently serves around 105,000 lives, grossing nearly $550 million of annual revenues from these regions.Molina Healthcare primarily serves via Medicaid, Medicare and other government-sponsored programs. The company is well-positioned to benefit from the increased participation of managed care in Medicaid.

In a year’s time, the stock has surged 39% compared with the industry’s growth of 30%. The stock should derive a further impetus as it is showing marked changes from the recently undertaken transformation initiatives. New leadership, cost-cutting efforts, profit improvement initiatives as well as a focus on improving efficiency of core operating processes, should aid the company’s results.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Molina Healthcare’s impressive first-quarter results, beating estimates by 111.11%, and a raised 2018 guidance bear evidence of early success achieved on its transformational plans.

Moreover, the company recently disclosed in detail its progress on turnaround initiatives, reflecting its solid position for growth.


Molina Healthcare carries a Zacks Rank #3 (Hold). Investors interested in the Medical HMO industry might take a look at some better-ranked stocks like WellCare Health Plans, Inc. (NYSE:WCG) and Triple-S Management Corporation (NYSE:GTS) .

WellCare offers managed care services for government-sponsored health care programs. Sporting a Zacks Rank #1 (Strong Buy), the company delivered an average four-quarter positive surprise of 51.70%. You can see the complete list of today’s Zacks #1 Rank stocks here.

Triple-S and its subsidiaries offer a portfolio of managed care and related products in the commercial, Medicare and Medicaid markets in Puerto Rico, the United States. It holds a Zacks Rank #2 (Buy) and came up with an average whopping four-quarter beat of 260.65%.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>





Molina Healthcare, Inc (MOH): Free Stock Analysis Report

WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report

Triple-S Management Corporation (GTS): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


DXC Technology Company. (DXC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.